Endothelial vasodilatory cannabinoid receptor in the human pulmonary artery: a future option in the therapy of pulmonary hypertension?
Hornig
Burkhard
B
Abteilung Kardiologie, St Claraspital, Basel, Switzerland. burkhard.hornig@claraspital.ch
D001095:Arachidonic Acids / Q000494:pharmacology; D063388:Endocannabinoids; D004730:Endothelium, Vascular / Q000502:physiology*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D053284:Polyunsaturated Alkamides / Q000494:pharmacology; D011651:Pulmonary Artery / Q000187:drug effects / Q000502:physiology*; D043882:Receptors, Cannabinoid / Q000032:analysis / Q000502:physiology*; D012118:Resorcinols / Q000494:pharmacology; D014664:Vasodilation
C479832:4-(3-3,4-p-menthadien-(1,8)-yl)olivetol; D001095:Arachidonic Acids; D063388:Endocannabinoids; D053284:Polyunsaturated Alkamides; D043882:Receptors, Cannabinoid; D012118:Resorcinols; C078814:anandamide